Etopophos 113.6 mg
Etopophos 113.6 mg is a medicine authorised by Swissmedic under authorisation number 53557. The authorisation holder is Cheplapharm Schweiz GmbH. The medicinal product code is Synthetic medicines and the dispensing category is A: Supplied only against a medical or veterinary prescription that may not be dispensed repeatedly. First authorisation was granted on 28 August 1996 and the authorisation is valid without a time limit. ATC code L01CB01 places the medicine in the group Antineoplastic agents.
| Authorisation number | 53557 |
|---|---|
| Name | Etopophos 113.6 mg |
| Full name | Etopophos 113.6 mg, Pulver zur Herstellung einer Infusionslösung |
| Authorisation holder | Cheplapharm Schweiz GmbH |
| Medicinal product code | Synthetic medicines |
| Dispensing category | A · Prescription, not repeatable |
| ATC code | L01CB01 |
| First authorisation | 28 August 1996 |
| Authorisation validity | unlimited |
| No. | Name | Dispensing category | Authorisation date |
|---|---|---|---|
| 1 | Etopophos 113.6 mg, Pulver zur Herstellung einer Infusionslösung | A | 28 August 1996 |
| 2 | Etopophos 1136 mg, Pulver zur Herstellung einer Infusionslösung | A | 28 February 2000 |
Scroll the table sideways
| Pack code | Quantity | Unit | ATC | IT code | Dispensing category |
|---|---|---|---|---|---|
| 23 | 1 | Durchstechflasche(n) | L01CB01 | 07.16.1. | A |
| 31 | 1 | Durchstechflasche(n) | L01CB01 | 07.16.1. | A |
Scroll the table sideways
Medicines in the same ATC group
Other medicines from this authorisation holder
Frequently asked questions
Is Etopophos 113.6 mg authorised in Switzerland?
Yes. Etopophos 113.6 mg is authorised by Swissmedic under authorisation number 53557, data as of 01 September 2026. The authorisation is valid without a time limit.
Which dispensing category does Etopophos 113.6 mg have?
Etopophos 113.6 mg is in dispensing category A. Supplied only against a medical or veterinary prescription that may not be dispensed repeatedly.
Who is the authorisation holder of Etopophos 113.6 mg?
The authorisation holder is Cheplapharm Schweiz GmbH. The holder carries the legal responsibility for quality, safety and product information of the medicine in Switzerland.
Sources
Swissmedic data as of 01 September 2026. No medical advice. Independent directory, not affiliated with Swissmedic or the FOPH.